Vinay Parikh Selected Research

Cognitive Dysfunction

4/2023	Septohippocampal cholinergic system at the intersection of stress and cognition: Current trends and translational implications.
1/2022	Disrupted Choline Clearance and Sustained Acetylcholine Release In Vivo by a Common Choline Transporter Coding Variant Associated with Poor Attentional Control in Humans.
1/2022	Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes.
8/2019	Repetitive mild concussion in subjects with a vulnerable cholinergic system: Lasting cholinergic-attentional impairments in CHT+/- mice.
1/2017	Developmental suppression of forebrain trkA receptors and attentional capacities in aging rats: A longitudinal study.
4/2016	Impact of partial dopamine depletion on cognitive flexibility in BDNF heterozygous mice.
2/2013	The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention.
1/2009	Phasic acetylcholine release and the volume transmission hypothesis: time to move on.
1/2008	Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity.
7/2007	Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinay Parikh Research Topics

Disease

10	Cognitive Dysfunction 04/2023 - 07/2007
7	Schizophrenia (Dementia Praecox) 01/2023 - 01/2003
4	Mental Disorders (Mental Disorder) 04/2024 - 01/2015
4	Tobacco Use Disorder (Nicotine Dependence) 01/2018 - 04/2015
3	Neuroinflammatory Diseases 02/2024 - 09/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 07/2007
2	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2015 - 02/2013
1	Inflammation (Inflammations) 11/2023
1	Ischemic Stroke 11/2023
1	Neurodevelopmental Disorders 01/2023
1	Nervous System Diseases (Neurological Disorders) 03/2021
1	Brain Concussion (Cerebral Concussion) 08/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2019
1	Wounds and Injuries (Trauma) 08/2019
1	Atrophy 01/2017
1	Anxiety Disorders (Anxiety Disorder) 01/2015
1	Neurobehavioral Manifestations 01/2008
1	Psychotic Disorders (Schizoaffective Disorder) 04/2003
1	Brain Injuries (Brain Injury) 04/2003

Drug/Important Bio-Agent (IBA)

10	Cholinergic Agents (Cholinergics)IBA 04/2024 - 05/2005
5	Nicotine FDA Link 01/2018 - 01/2015
4	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2003
3	choline transporterIBA 01/2022 - 02/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2014
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2016 - 01/2015
2	Neurotransmitter Agents (Neurotransmitter)IBA 11/2023 - 07/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024
1	Nerve Growth Factors (Neurotrophins)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	Viral ProteinsIBA 03/2021
1	NeuregulinsIBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 04/2016
1	Corticotropin-Releasing HormoneIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 11/2014
1	Choline (Choline Chloride)IBA 02/2013
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 08/2007
1	Nerve Growth Factor (NGF)IBA 04/2003
1	Polytetrafluoroethylene (Teflon)FDA Link 04/2003
1	Haloperidol (Haldol)FDA LinkGeneric 02/2003
1	EnzymesIBA 01/2003
1	AntioxidantsIBA 01/2003

Therapy/Procedure

1	Vagus Nerve Stimulation 11/2023
1	Therapeutics 01/2023
1	Self Medication 03/2016